ABBVbenzinga

Cantor Fitzgerald Initiates Coverage On AbbVie with Overweight Rating, Announces Price Target of $200

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 17, 2024 by benzinga